In colorectal cancer, LIF downregulates and promotes degradation of p53 via STAT3/ID1/MDM2 [83]; conversely, p53 has been seen to be a positive regulator of LIF in medulloblastoma cells [84] and a negative regulator of LIF in leiomyoma cells [85]. Here, LIF is linked to leiomyoma.